DIERENDOKTERS
ActiveSummary
DIERENDOKTERS has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €106,891 and a net result of -€5,017. Equity is growing by about 7.4% per year across the filed financial years. Its solvency ranks better than 94% of 1,592 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 24 days late
2025
31-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 31 days late
2024
31-12
Financial
Back to profitnet €14,457
Net result €14,457 after one loss-making year.
31-12
Financial
Equity above €100,000equity €111,908 ▲14.8%
Equity rises from €97,451 to €111,908.
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
2023
31-12
Financial
Weakest financial yearnet -€8,664
Net result drops to -€8,664, the lowest in the series; recovery starts the following year.
28-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 28 days late
2022
31-12
Financial
Liquidity doublescurrent ratio 4.67
Current ratio from 2.29 to 4.67; short-term debt falls from €44,871 to €25,697.
31-12
Financial
Equity above €100,000equity €106,115 ▲46.4%
A profit in every financial year since 2021 builds equity to €106,115.
22-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 22 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.